Success Metrics

Completion Rate
0%(0/1)
Active Trials
3(50%)
Terminated
1(17%)

Phase Distribution

Ph phase_2
1
17%
Ph early_phase_1
2
33%
Ph not_applicable
2
33%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Terminated(1)
Other(1)

Detailed Status

Recruiting2
Terminated1
Active, not recruiting1
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (40.0%)
Phase 21 (20.0%)
N/A2 (40.0%)

Trials by Status

terminated117%
active_not_recruiting117%
unknown117%
not_yet_recruiting117%
recruiting233%

Recent Activity

3 active trials
Showing 5 of 6
active_not_recruitingphase_2

Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT06497062
recruitingearly_phase_1

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

NCT06787560
recruitingearly_phase_1

Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD

NCT06769191
not_yet_recruitingnot_applicable

Allo-HSCT vs ASCT in Adult T-LBL

NCT06741813
unknownnot_applicable

The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission

NCT05339204
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06497062Phase 2

Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia

Active Not Recruiting
NCT06787560Early Phase 1

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

Recruiting
NCT06769191Early Phase 1

Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD

Recruiting
NCT06741813Not Applicable

Allo-HSCT vs ASCT in Adult T-LBL

Not Yet Recruiting
NCT05339204Not Applicable

The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission

Unknown
NCT02204904

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Terminated

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6